Ledger.Open graph →
SEC Form D · Amendment · filed May 15, 2017

Sienna Biopharmaceuticals, Inc

Offering
$50.0M
Sold
$46.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Weslake Village, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Paul F. Lizzul · Westlake Village, CAExecTodd C. Harris · Westlake Village, CAExec · DirectorDiane F. Stroehmann · Westlake Village, CAExecTimothy K. Andrews · Westlake Village, CAExecKristina R. Burow · Westlake Village, CADirectorBob R. More · Westlake Village, CADirectorArie N. Page · Vancouver, British Columbia, CanadaExecGene Gutman · Menomonie, WIExecRita J. King · Morrisville, NCExec · DirectorQuoc Ngo · Boise, IDExecKeith R. Leonard Jr · Westlake Village, CADirectorRobert R. Nelsen · Westlake Village, CADirectorFrederick C. Beddingfield Iii · Westlake Village, CAExec · DirectorRic C. Peterson · Westlake Village, CAExecDennis R. Fenton · Westlake Village, CADirectorPaul Burton · Boise, IDExecJohn J. Mccleary · Vancouver, British Columbia, CanadaExecGeorgia M. Erbez · La Jolla, CAExec · DirectorThom Ives · Boise, IDExecKeith R. Leonard Jr · Westlake Village, CADirectorKristina R. Burow · Westlake Village, CADirectorRobert R. Nelsen · Westlake Village, CADirectorFrederick C. Beddingfield Iii · Westlake Village, CAExec · DirectorRic C. Peterson · Westlake Village, CAExecBob R. More · Westlake Village, CADirectorDennis R. Fenton · Westlake Village, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗